SCM
TMO icon

Shelton Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Shelton Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.19M Sell
6,490
-2,555
-28% -$1.39M 0.07% 180
2025
Q4 		$5.24M Buy
9,045
+5,300
+142% +$3M 0.1% 157
2025
Q3 		$1.82M Sell
3,745
-55
-1% -$25.6K 0.04% 225
2025
Q2 		$1.54M Sell
3,800
-40
-1% -$16.7K 0.04% 244
2025
Q1 		$1.91M Sell
3,840
-18
-0.5% -$9.75K 0.05% 230
2024
Q4 		$2.01M Sell
3,858
-40
-1% -$22K 0.05% 229
2024
Q3 		$2.41M Sell
3,898
-88
-2% -$52.1K 0.06% 227
2024
Q2 		$2.2M Hold
3,986
– – 0.06% 234
2024
Q1 		$2.32M Buy
3,986
+1,700
+74% +$954K 0.07% 240
2023
Q4 		$1.21M Sell
2,286
-130
-5% -$62.9K 0.04% 263
2023
Q3 		$1.22M Hold
2,416
– – 0.04% 257
2023
Q2 		$1.26M Sell
2,416
-4
-0.2% -$2.16K 0.05% 256
2023
Q1 		$1.39M Sell
2,420
-51
-2% -$28.7K 0.06% 227
2022
Q4 		$1.36M Hold
2,471
– – 0.14% 186
2022
Q3 		$1.25M Sell
2,471
-25
-1% -$14K 0.06% 228
2022
Q2 		$1.36M Sell
2,496
-407
-14% -$224K 0.06% 235
2022
Q1 		$1.72M Hold
2,903
– – 0.06% 239
2021
Q4 		$1.94M Sell
2,903
-32
-1% -$20K 0.07% 239
2021
Q3 		$1.68M Buy
2,935
+373
+15% +$205K 0.07% 240
2021
Q2 		$1.29M Sell
2,562
-2,562
-50% -$1.21M 0.05% 258
2021
Q1 		$2.34M Buy
5,124
+2,505
+96% +$1.2M 0.08% 222
2020
Q4 		$1.22M Sell
2,619
-9,954
-79% -$4.67M 0.05% 251
2020
Q3 		$5.55M Buy
12,573
+9,815
+356% +$4.05M 0.23% 90
2020
Q2 		$999K Sell
2,758
-70
-2% -$23.5K 0.06% 252
2020
Q1 		$802K Hold
2,828
– – 0.06% 239
2019
Q4 		$919K Sell
2,828
-234
-8% -$71K 0.05% 247
2019
Q3 		$892K Hold
3,062
– – 0.05% 240
2019
Q2 		$899K Buy
3,062
+2,224
+265% +$613K 0.05% 247
2019
Q1 		$3.06K Sell
838
-2,224
-73% -$553K 0.01% 714
2018
Q4 		$685K Hold
3,062
– – 0.05% 259
2018
Q3 		$747K Hold
3,062
– – 0.04% 275
2018
Q2 		$634K Hold
3,062
– – 0.04% 295
2018
Q1 		$632K Hold
3,062
– – 0.04% 309
2017
Q4 		$581K Hold
3,062
– – 0.04% 336
2017
Q3 		$579K Sell
3,062
-12,200
-80% -$2.21M 0.04% 323
2017
Q2 		$4.09M Sell
15,262
-200
-1% -$33.6K 0.29% 76
2017
Q1 		$2.38M Buy
15,462
+4,104
+36% +$627K 0.16% 120
2016
Q4 		$1.6M Sell
11,358
-300
-3% -$44.2K 0.12% 172
2016
Q3 		$1.85M Sell
11,658
-3,302
-22% -$509K 0.15% 129
2016
Q2 		$2.21M Sell
14,960
-198
-1% -$29.2K 0.19% 104
2016
Q1 		$2.15M Buy
15,158
+100
+0.7% +$13.4K 0.19% 101
2015
Q4 		$2.14M Sell
15,058
-800
-5% -$107K 0.21% 101
2015
Q3 		$1.94M Buy
15,858
+1,700
+12% +$221K 0.21% 98
2015
Q2 		$1.84M Hold
14,158
– – 0.19% 109
2015
Q1 		$1.9M Sell
14,158
-2,600
-16% -$335K 0.21% 106
2014
Q4 		$2.1M Buy
16,758
+4,900
+41% +$596K 0.24% 89
2014
Q3 		$1.44M Buy
11,858
+1,100
+10% +$134K 0.19% 104
2014
Q2 		$1.27M Buy
10,758
+900
+9% +$106K 0.18% 112
2014
Q1 		$1.19M Hold
9,858
– – 0.17% 116
2013
Q4 		$1.1M Hold
9,858
– – 0.17% 120
2013
Q3 		$908K Buy
9,858
+7,200
+271% +$651K 0.15% 139
2013
Q2 		$225K Buy
+2,658
New +$221K 0.04% 554

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Shelton Capital Management's TMO Position: Q1 2026 in Review

Shelton Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 28% in Q1 2026, selling an estimated $1.39M and leaving 6,490 shares worth $3.19M. The position accounts for 0.07% of the portfolio, ranked #180.

Shelton Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.55M in Q3 2020. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Shelton Capital Management held 6,490 shares of Thermo Fisher Scientific worth $3.19M as of Q1 2026.
  • Shelton Capital Management sold 2,555 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.39M.
  • Thermo Fisher Scientific made up 0.07% of Shelton Capital Management's portfolio in Q1 2026, its #180 holding.
  • Shelton Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Shelton Capital Management's Thermo Fisher Scientific position peaked at $5.55M in Q3 2020.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.